Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells
South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific cellular "switches" that drive tumor...
Search results for "WHO"
Over 65 and Shut Out of Stem Cell Transplants? Fitness, Not Age, Should Guide Multiple Myeloma Care
Older adults diagnosed with multiple myeloma should not automatically be ruled out for autologous hematopoietic stem cell transplantation simply...
Singer Baek Ji-young Warns Brides-to-Be: Choose Proven Skin Procedures Before the Big Day
Singer Baek Ji-young recently offered practical advice for brides-to-be considering aesthetic skin procedures ahead of...
Sudden Cold Sweats and Blurred Vision: Why You Should Lie Down, Not Tough It Out
A sudden wave of nausea hits, cold sweat breaks out, vision blurs, ears feel plugged, and a profound weakness sweeps...
First-Month Pressure Control Key to Saving Vision After Severe Glaucoma Surgery
Glaucoma causes irreversible optic nerve damage, leaving clinicians with a single paramount objective once the disease...
Nearly 4 in 10 Patients Continue Smoking After Cancer Diagnosis: Quitting Slashes Cardiovascular Risk by 36%
A cancer diagnosis is often considered a powerful catalyst for lifestyle changes, yet real-world data reveals that...
Uijeongbu Eulji University Hospital Launches Beomseok Memorial Cancer Hospital to Streamline Patient Care
Uijeongbu Eulji University Hospital is launching an integrated cancer care system designed to eliminate the logistical...
Choosing Salmon to Lose Weight? How You Eat It Could Add Belly Fat and Strain Blood Vessels
When managing weight, many people reach for salmon instead of chicken breast. Whether served over a salad or stacked on...
TV Personality Park Ji-yoon Drops to 55 kg: The Science Behind Her High-Satiety Breakfast Routine
TV personality Park Ji-yoon has drawn widespread attention after revealing a newly defined waistline and a toned...
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate
Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name:...